𝔖 Bobbio Scriptorium
✦   LIBER   ✦

II.P11 Executive dysfunction and frontostriatal circuits in Parkinson's Disease: A fMRI study

✍ Scribed by I. Reuter; G. Sammer; M. Kirsch; K. Morgen; D. Vaitl

Book ID
117752197
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
50 KB
Volume
12
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hyposmia and executive dysfunction as pr
Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study
✍ Mirthe M. Ponsen; Diederick Stoffers; Jos W.R. Twisk; Erik Ch. Wolters; Henk W. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 69 KB

## Abstract Olfactory deficits and executive dysfunction are early and common symptoms in Parkinson's disease (PD). Previous studies have shown that hyposmia can be a first sign of PD. The aim of the present study was to determine which of three olfactory tests and two selected tests of executive f

Atomoxetine for the treatment of executi
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open-label study
✍ Laura Marsh; Kevin Biglan; Melissa Gerstenhaber; James R. Williams πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 1 views

## Abstract Executive dysfunction (ED) is a prominent and often disabling feature of cognitive impairment in Parkinson's disease (PD). Few studies have examined treatments. Given the role of noradrenergic pathology in ED, atomoxetine, a norepinephrine reuptake inhibitor indicated for attention defi